| First Author | Suzuki T | Year | 2025 |
| Journal | Biochim Biophys Acta Mol Cell Biol Lipids | Volume | 1870 |
| Issue | 1 | Pages | 159563 |
| PubMed ID | 39332666 | Mgi Jnum | J:358084 |
| Mgi Id | MGI:7738136 | Doi | 10.1016/j.bbalip.2024.159563 |
| Citation | Suzuki T, et al. (2024) Re-evaluation of the canonical PAF pathway in cutaneous anaphylaxis. Biochim Biophys Acta Mol Cell Biol Lipids 1870(1):159563 |
| abstractText | Platelet-activating factor (PAF) is a potent classical lipid mediator that plays a critical role in various diseases such as allergy and nervous system disorders. In the realm of allergy, previous studies suggested that PAF is generated in response to extracellular stimuli and contributes to allergic reactions via PAF receptor (PAFR). However, the sources of endogenous PAF and its pathophysiological dynamics remain largely elusive in vivo. Here, we report that rapid and local PAF generation completely depends on lysophospholipid acyltransferase 9 (LPLAT9, also known as LPCAT2) expressed in mast cells in IgE-mediated passive cutaneous anaphylaxis. However, we found that LPLAT9 knockout (KO) mice did not display attenuated vascular leakage. Additionally, decreased vascular leakage was observed in PAFR KO mice, but not in endothelial cell-specific mice in this model. These divergences highlight a yet unsolved complexity of the biological functions of PAF and PAFR in a pathophysiological process. |
